ACTIVE LAWSUIT!

SEE IF YOU QUALIFY

Prevacid Acute Lawsuit

Prevacid, a popular heartburn drug used to treat gastroesophageal reflux disease (GERD) and ulcers, has been linked to an increased risk for developing chronic kidney disease, acute kidney injury, acute interstitial nephritis, heart attack, and other health risks.
Award Logos
C.L. Mike Schmidt Published by C.L. Mike Schmidt

Free Confidential Prevacid Lawsuit Evaluation: If you or a loved one was injured by Prevacid side effects, you should contact our law firm immediately for a free case evaluation. You may be entitled to financial compensation by filing a suit against Takeda Pharmaceuticals or other drug manufacturers and a Prevacid lawyer can help.

Millions of people rely on Prevacid and other proton pump inhibitors (PPIs) to manage heartburn, acid reflux, and ulcers.

While these medications are effective, recent studies have raised concerns about their long-term safety, particularly their link to serious kidney issues and other complications.

If you’re currently taking a PPI, it’s important to stay informed about potential side effects, warning signs, and safer alternatives.

Understanding the risks can help you take proactive steps to protect your health, from monitoring symptoms to exploring alternative treatments. Here’s what you need to know to make the best decision for your well-being.

Update: PPI Acid Reflux Drugs Increase Stomach Cancer Risk by up to 250%, Study Finds

According to the British Society of Gastroenterology, extended use of PPIs (3 years or more) can elevate your risk of life-threatening stomach cancer by up to 250%, a new study has found [3].

For short-term treatment, the drugs have proved safe for blocking too much acid production.

However, for a small percentage of people who carry a bacterium called Helicobacter pylori, the risk of developing stomach cancer increases dramatically when they take a PPI for an extended period, the researchers found.

Overview

product sample of prevacidManufactured and marketed by Takeda Pharmaceuticals, Prevacid (also called Prevacid NapraPAC) is a prescription and over-the-counter slow-release capsule used to reduce the amount of stomach acid produced in the body.

Prevacid was approved by the U.S. Food and Drug Administration in May 1995 and is part of a family of dangerous drugs known as proton pump inhibitors (PPIs), which are designed to treat gastroesophageal reflux disease and peptic ulcer disease.

Prevacid and other proton pump inhibitors are extremely popular and widely used, with doctors writing nearly 115 million prescriptions for the medications each year nationwide.

Other Takeda Pharmaceuticals Lawsuit We’ve Taken On:

The Hidden Dangers of Prevacid and PPIs: Understanding the Health Risks

Proton pump inhibitors (PPIs) like Prevacid, Nexium, and Prilosec are commonly used for treating acid reflux, heartburn, and ulcers, but growing research links long-term use to severe kidney damage and other serious health complications.

Understanding these risks is essential for those taking PPIs regularly. Below is a breakdown of immediate dangers, long-term risks, contributing factors, and necessary medical monitoring.

Immediate Risks: Acute Kidney Injury (AKI)

Acute kidney injury (AKI) is a sudden decline in kidney function, often triggered by inflammation or decreased blood flow. PPIs have been shown to increase the risk of AKI, potentially leading to long-term damage.

Study Findings on Acute Kidney Injurykidney anatomy

According to the National Heart, Lung, and Blood Institute (NHLBI), researchers examined 10,482 subjects in the Atherosclerosis Risk in Communities (ARIC) study to assess the impact of PPIs on kidney health [2]:

  • Patients were monitored for a median of 13.9 years.
  • At the beginning of the study, 3.1% (322 subjects) regularly used PPIs.
  • After adjusting for variables, Prevacid and other PPIs were linked to a 20–50% increased risk of chronic kidney disease (CKD).

Symptoms of Acute Kidney Injury:

  • Sudden swelling in legs, ankles, or feet
  • Decreased or no urine output
  • Severe fatigue or confusion
  • Shortness of breath

According to a study published in JAMA Internal Medicine, PPIs like Prevacid increase the risk of AKI by 20–50%, leading researchers to believe they are a major contributor to rising kidney disease cases [3].

Long-Term Risks: Chronic Kidney Disease (CKD)

Prolonged use of PPIs has been linked to chronic kidney disease (CKD), a progressive condition that may eventually lead to kidney failure.

CKD affects 13.6% of adults in the U.S. and is associated with a higher risk of death and cardiovascular complications.

Stages of Chronic Kidney Disease (Based on GFR Levels)

Stage GFR Level (mL/min) Kidney Function
Stage 1 90+ Normal function but with structural abnormalities or urine findings.
Stage 2 60-89 Mildly reduced function with signs of kidney disease.
Stage 3A 45-59 Moderate loss of kidney function.
Stage 3B 30-44 More significant reduction in function.
Stage 4 15-29 Severe kidney impairment.
Stage 5 <15 (or on dialysis) Kidney failure, requiring dialysis or transplant.

Symptoms of CKDman holding his stomach in pain

  • Persistent nausea, vomiting, and appetite loss
  • Swelling and fluid retention
  • High blood pressure
  • Back pain just below the rib cage (flank pain)
  • Confusion, anxiety, restlessness, or excessive sleepiness

Research suggests that PPIs contribute to kidney damage at a faster rate than conditions like diabetes and hypertension, making them a significant but preventable risk factor.

Alarming Health Risks Associated with Long-Term PPI Use

Recent studies have uncovered serious health risks linked to prolonged use of proton pump inhibitors (PPIs) such as Prevacid, Nexium, and Prilosec.

These risks go beyond digestive health concerns, revealing potential life-threatening complications affecting the kidneys, heart, lungs, and brain.

Study Finds Risk of Death with PPI Heartburn Medications

July 5, 2017 – As claimed by the BMJ JOurnals, PPIs like Nexium/Prilosec have been linked to a 25% greater risk of kidney transplant and death compared to patients who took H2 blockers, according to a study published Monday in BMJ [4].

The study also found that PPI use was linked to a 15% increased death rate compared to patients who took another kind of acid suppressor other than H2 blockers and that the death rate was 23% higher among PPI users compared to people who took no such medications.

Choose our lawyers

Have you or a loved one suffered from the adverse side effects caused by defective medication?

PPIs Linked to Increased Risk of Pneumonia in Dementia Patients

April 5, 2017 – Dementia patients who take PPIs like Nexium/Prilosec have an 89% increased risk of developing pneumonia compared to dementia patients who don’t use the medications, according to a study published last month in the Journal of the American Geriatrics Society.

Independent risk factors for pneumonia included age, male gender, underlying cerebrovascular disease, chronic pulmonary disease, congestive heart failure, diabetes mellitus, Zollinger-Ellison Syndrome, and antipsychotic use.

PPIs Linked to Increased Risk for Heart Failure, Death

old man in his death bedMarch 23, 2017 – According to the PLOS Organization, proton pump inhibitor (PPI) heartburn medicines have been linked to an increased risk of heart failure and death in patients with coronary artery disease (CAD), according to a recent study published in PLOS ONE [6].

The researchers found that PPIs like Nexium/Prilosec are commonly used to prevent complications in CAD patients treated with chronic antiplatelet therapy (aspirin, Plavix, Effient).

However, when used in this capacity, PPIs may increase the risk of adverse health consequences including kidney disease, pneumonia, micronutrient deficiencies, and osteoporosis-related fractures.

Acid Reflux Drugs Linked to Brain Problems, Fluid Buildup

stack of white capsulesSeptember 1, 2016 – As claimed by the American Association for the Study of Liver Diseases, a new study has found that proton pump inhibitors may cause loss of brain function (hepatic encephalopathy or “HE”) and fluid buildup in the abdomen (ascites) [6].

The study’s original objective was to determine the efficacy of a treatment for ascites.

However, they found that PPIs may cause abdominal fluid accumulation and HE, a loss of brain function that occurs when the liver is unable to remove toxins from the blood.

Study Finds Increased Kidney Failure, Cardiovascular Complications w/ Proton Pump Inhibitors

August 19, 2016 – Prevacid and other proton pump inhibitor heartburn medications have already been linked to several severe health risks like chronic kidney injury and acute interstitial nephritis.

According to the International Journal of Cardiology, add cardiovascular complications in patients with heart disease to that list, according to a June study published in the International Journal of Cardiology. [7]

The researchers found that prolonged PPI use was associated with an increased risk for anemia, interstitial nephritis, lower weight, a worsening metabolic profile, and under-utilization of cardioprotective drugs (like statins and blood pressure drugs).

Check out the other similar dangerous drug lawsuits we’ve taken on.

Study Finds Heartburn Drugs Increase Risk of Rhabdomyolysis

September 26, 2016 – A new case study suggests that a skeletal muscle disorder known as rhabdomyolysis may be another potential side effect of proton pump inhibitors.

According to the Medicine Journal study, the Organization described a 45-year-old patient who developed the condition shortly after being treated with an intravenous dose of Nexium (esomeprazole) for chest pain. The findings were published in last month’s edition of Medicine [8].

PPI Heartburn Meds Linked to Kidney Failure… Again

April 14, 2016 – As claimed by the Journal of the American Society of Nephrology, people who use proton pump inhibitors (PPIs) like Nexium / Prilosec are more likely than those who take histamine H2 receptor blockers (Pepcid, Tagamet, Zantac) to develop health risks including kidney problems and renal failure, a new study suggests [9].

Related Article: Zantac Attorneys

The new findings are based on the records of more than 173,000 VA patients who have been prescribed a PPI and over 20,000 other patients who took H2-blockers.

For 5 years, 15% of PPI users developed CKD, versus 11% of those on H2-blockers. After other factors were calculated, PPI users still had a 28% greater risk of serious kidney injuries.

Statistics Highlighting the Risks

man with his hands on his sides

A study conducted on 10,482 participants as part of the Atherosclerosis Risk in Communities (ARIC) study provided significant insights into the dangers of PPIs:

  • The average participant age was 63 years old (with a standard deviation of 5.6 years).
  • 43.9% of participants were male.
  • Chronic Kidney Disease (CKD) affects 13.6% of U.S. adults, significantly increasing the risk of death and cardiovascular events.
  • PPIs are among the most commonly prescribed drugs in the U.S., yet an estimated 25% to 70% of prescriptions lack appropriate medical justification.

As more evidence emerges, experts warn that millions of people may be at risk of severe complications from long-term PPI use.

Given the high prescription rates and potentially unnecessary use, it is critical for patients to be informed of these risks and consider alternative treatment options where possible.

Who Is at Higher Risk?

Certain individuals face a greater risk of kidney damage and other complications when using PPIs:

  • Older adults (60+)
  • People with preexisting kidney disease or diabetes
  • Long-term PPI users (one or more years of continuous use)
  • Individuals on multiple medications affecting kidney function

If you fall into any of these groups, it is critical to discuss alternative treatments with your doctor.

Medical Monitoring for PPI Users

If you are taking Prevacid or other PPIs long-term, regular health monitoring is essential to detect complications early.

Recommended Tests

  • Kidney function tests (GFR, creatinine levels, blood urea nitrogen)
  • Electrolyte balance (magnesium, calcium, and potassium levels)
  • Blood pressure checks (to track kidney-related hypertension)

Doctors may recommend gradually reducing PPI use or switching to H2 blockers (Pepcid, Zantac) as a safer alternative.

Lifestyle changes such as diet modifications, weight loss, and stress management can also help manage heartburn without medication.

Related Articles:

Compensation Information: Prevacid Acute Lawsuit

If you or a loved one has suffered health complications due to Prevacid, understanding your legal rights and potential compensation is essential.

Lawsuits allege that drug manufacturers failed to warn consumers about the severe risks associated with long-term PPI use, particularly kidney disease and related complications.

Compensation in these cases can help cover medical costs, lost wages, and other damages incurred due to the medication’s side effects.

Types of Damages Available

Those affected by Prevacid-related injuries may be eligible for compensation through two primary types of damages:

1. Compensatory Damages

  • Medical Expenses: Covers hospital visits, surgeries, dialysis treatments, and ongoing care related to kidney disease.
  • Pain and Suffering: Compensation for physical discomfort, emotional distress, and decreased quality of life.
  • Lost Wages: Reimbursement for income lost due to time off work for treatment or disability caused by kidney failure.
  • Emotional Distress: Compensation for psychological and emotional trauma resulting from the illness.

2. Punitive Damages

  • Awarded in cases where the defendant’s conduct was found to be reckless or negligent, serving as a deterrent for future misconduct.
  • Typically applicable in lawsuits where manufacturers failed to disclose known risks associated with Prevacid use.

By understanding the scope of damages available, victims can seek financial relief to manage medical treatments and other challenges resulting from their condition.

Recent Settlement Amounts

While specific Prevacid-related settlements are still being pursued, similar proton pump inhibitor (PPI) lawsuits have resulted in significant financial payouts:

  • October 2023: A $425 million settlement was reached involving multiple PPI-related claims[3].
  • Pfizer Settlement: The pharmaceutical company paid $839 million to resolve allegations regarding Protonix misbranding and safety concerns.

These cases demonstrate the potential for substantial settlements in PPI-related litigation, providing precedent for those pursuing claims against Prevacid manufacturers.

Coverage for Ongoing Medical Care

Chronic kidney disease, kidney failure, and other conditions linked to Prevacid often require long-term medical care.

Compensation can help cover:

1. Future Medical Expenses

  • Dialysis Treatments: If kidney failure occurs, claimants may receive funds for ongoing dialysis and transplant-related expenses.
  • Regular Kidney Monitoring: Chronic kidney disease requires lifelong medical oversight through blood tests, imaging, and specialist visits.

2. Quality of Life Adjustments

  • Individuals suffering from severe kidney disease may need compensation for assistive care, home modifications, or lifestyle changes necessary due to their condition.

By securing financial assistance for ongoing healthcare needs, claimants can focus on managing their illness without the additional stress of mounting medical expenses.

Lost Wages and Future Income Loss

For many individuals, kidney disease and other complications from Prevacid use have forced them to miss work or leave their jobs entirely.

Compensation for lost wages can include:

  • Short-Term Income Loss: Covering wages lost due to time off for medical appointments, treatments, or hospitalizations.
  • Long-Term Disability Compensation: If kidney disease results in permanent work limitations, claimants may be entitled to compensation for reduced earning capacity.

To strengthen a claim for lost wages, individuals should provide:

  • Employment records documenting missed workdays.
  • Medical records proving the illness prevents full-time employment.
  • Expert testimony regarding future earning potential if the condition worsens.

By securing compensation for financial losses, affected individuals can receive fair reimbursement for the long-term impact of their illness.

Future Medical Expenses

In many cases, claimants are awarded compensation based on the expected long-term costs of treating Prevacid-related health issues.

This includes:

  • Projected Costs: Future treatments such as transplants, dialysis, and specialist visits.
  • Rehabilitation and Therapy: Costs associated with physical therapy, dietary management, and lifestyle modifications.
  • Psychological and Emotional Support: Some claimants receive compensation for therapy and mental health services to cope with the stress of chronic illness.

Ensuring these future expenses are covered can help claimants manage the long-term impact of their condition without financial strain.

Due to the growing number of kidney disease cases linked to PPIs, lawsuits have been filed against manufacturers for failure to provide adequate warnings about these risks.

PPI Suits Centralized in New Jersey

new jersey city August 4, 2017 – The U.S. Judicial Panel on Multidistrict Litigation (JPML) on Wednesday ordered that all federally filed Prevacid lawsuits and other PPI lawsuits will be consolidated in the District Court in New Jersey for pretrial handling.

The panel’s ruling marked an about-face from its previous opinion on the matter, having February rejected a bid to create an MDL.

The reason for the change was due to the litigation’s substantial increase in size since the initial ruling, and because 2 defendants who previously opposed adequate warnings in Prevacid lawsuits — AstraZeneca and Pfizer — are now in support of it, according to JPML.

MDL Proposed for Prevacid Serious Kidney Injury Product Liability Lawsuits

October 20, 2016 – Patients who suffered serious kidney injuries after taking Prevacid and other PPI heartburn medications have filed a request seeking consolidation of class action lawsuits in an MDL in the Middle District of Louisiana.

Plaintiffs in proton pump inhibitor lawsuits allege that without the creation of an MDL, there exists “the possibility of inconsistent pretrial rulings exists, especially concerning the proper scope and extent of discovery, causation, and other factual and legal issues.”

Related Article: Prevacid Class Action Lawsuit

Lawsuit Qualification: Prevacid Acute Kidney Injury Lawsuit

If you or a loved one developed kidney disease or other severe health issues after using Prevacid or another proton pump inhibitor (PPI), you may be eligible for legal action.

Lawsuits claim that drug manufacturers failed to warn consumers about the potential risks associated with long-term use, particularly kidney-related complications.

Usage Requirements

To qualify for a lawsuit, claimants must demonstrate a history of regular and prolonged Prevacid use, which typically includes:

  • Duration of Use: A minimum of several months to years of continuous or frequent use.
  • Frequency of Use: Daily use or as prescribed by a physician.
  • Over-the-Counter or Prescription: Proof of either prescription or over-the-counter use is required to establish eligibility.

Medical Diagnosis Requirements

A verified medical diagnosis of a serious health condition linked to PPI use is essential. Eligible diagnoses include:

  • Acute Kidney Injury (AKI)
  • Chronic Kidney Disease (CKD) (any stage)
  • Kidney Failure (Renal Failure)
  • Kidney Transplant Requirement
  • Gastric Cancer or Other Digestive Cancers (in some cases)

These conditions must be diagnosed by a licensed medical professional, with medical records linking the diagnosis to prolonged PPI use.

Time Limitations for Filing a Lawsuit

Understanding legal deadlines is critical, as each state imposes a statute of limitations on product liability claims.

  • Standard Timeframe: Most states require lawsuits to be filed within 1 to 3 years from the date symptoms appeared or when they should have been reasonably discovered.
  • State-Specific Rules: Some states impose stricter deadlines, while others allow extensions under the discovery rule if the plaintiff was unaware of the connection between Prevacid and their condition.

For example:

  • Kentucky & Louisiana have shorter time limits for filing product liability lawsuits.
  • California & New York have more flexible rules, allowing claims to be filed later if the injury was discovered after prolonged use.

Consulting an attorney as soon as possible ensures compliance with these deadlines.

Documentation Needed to Support Your Claim

To strengthen your case, proper documentation is essential. Gathering the following medical and prescription records helps establish causation between Prevacid use and kidney-related injuries:

  • Required Medical Tests: Blood tests, urinalysis, kidney function tests (glomerular filtration rate (GFR), creatinine levels), and imaging (MRI, CT scans, ultrasounds).
  • Specialist Evaluations: Reports from nephrologists (kidney specialists) or gastroenterologists confirming the link between Prevacid and the diagnosed condition.
  • Timeline of Symptoms: A detailed timeline documenting the onset of symptoms, medical visits, and progression of the disease.
  • Prescription Records: Pharmacy records proving continuous use of Prevacid or another PPI over time.
  • Alternative Medication History: Documentation of any other treatments attempted, including H2 blockers (e.g., Zantac, Pepcid) as a potential alternative to PPIs.

Having detailed medical and pharmaceutical records strengthens a claim and increases the likelihood of a successful lawsuit outcome.

Next Steps: Speak with a Legal Expert

If you meet the above criteria and believe your health has been compromised by Prevacid or another PPI, consulting an attorney experienced in pharmaceutical litigation is the next step.

They can:

  1. Review your medical records and prescription history.
  2. Determine the best legal approach based on your state’s statute of limitations.
  3. Help gather expert testimony to support your case.

For more information on filing a Prevacid Acute Kidney Injury Lawsuit, contact a product liability attorney as soon as possible.

Legal action may provide compensation for medical expenses, lost wages, pain and suffering, and other damages caused by negligent drug manufacturers.

FAQs

Have manufacturers been held liable for Prevacid injuries?

Manufacturers have faced numerous lawsuits and have been ordered to pay settlements and verdicts in several cases. Outcomes vary depending on the specifics of each case and the evidence presented.

Can I receive a free legal consultation for a Prevacid lawsuit?

Many law firms offer free initial consultations to discuss the merits of your case. This allows you to explore your legal options without financial commitment.

What should I do if I suspect my injury is linked to Prevacid use?

Document the incident and your symptoms, retain any medical records and proof of Prevacid use, seek medical treatment, and consult with a lawyer experienced in pharmaceutical litigation. Prompt action is essential for building a strong case.

Are there alternatives to Prevacid that do not carry the same risks?

Yes, there are alternative medications for treating acid-related conditions, such as H2 blockers and lifestyle changes. Consulting with a healthcare provider can help identify safer alternatives based on your specific condition.

Get a Free Prevacid Lawsuit Evaluation With Our Lawyers

The Pharmaceutical Litigation Group at Schmidt & Clark, LLP law firm is an experienced team of trial lawyers that focus on the legal representation of plaintiffs in Prevacid lawsuits. We are handling individual litigation nationwide and currently investigating potential Prevacid lawsuits in all 50 states.

Free Confidential Case Evaluation: Again, if you have kidney problems after taking a heartburn medication, you should contact our law firm immediately. You may be entitled to financial compensation by filing a Prevacid lawsuit and our lawyers can help.

Reference:

  1. http://gut.bmj.com/content/early/2017/09/18/gutjnl-2017-314605
  2. https://www.nhlbi.nih.gov/science/population-and-epidemiology-studies
  3. http://gut.bmj.com/content/early/2017/09/18/gutjnl-2017-314605
  4. https://bmjopen.bmj.com/content/7/6/e015735
  5. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0169826
  6. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0169826
  7. https://www.internationaljournalofcardiology.com/article/S0167-5273(16)31065-8/abstract
  8. http://journals.lww.com/md-journal/Fulltext/2016/07190/Rhabdomyolysis_associated_with_single_dose.50.aspx
  9. http://journals.lww.com/jasn/pages/default.aspx

Get a Free Case Review

You may be entitled to financial compensation.
Secure Submission